SCHEMBL6399608

SCHEMBL6399608

CC(C)c1ccccc1NO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.53
GABRA1 P14867 3/20 0.50
GABRB2 P47870 2/20 0.50
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
POLB P06746 1/20 0.48
GABRG2 P18507 2/20 0.46
GABRB3 P28472 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
FAAH O00519 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10914403 0.84 L3MBTL1 (0.38) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL29148797 0.80 GABRA1 (0.46) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL3958491 0.80 L3MBTL1 (0.57) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL9764653 0.80 L3MBTL1 (0.57) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL2737240 0.78 L3MBTL1 (0.55) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL3217546 0.76 L3MBTL1 (0.53) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL18991348 0.76 L3MBTL1 (0.53) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL2860733 0.76 L3MBTL1 (0.53) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL20743821 0.76 L3MBTL1 (0.53) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL892805 0.76 L3MBTL1 (0.53) L3MBTL1GABRA1GABRB2GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953866-B2 Process for preparing ortho substituted phenylamines CROMPTON CORPORATION (US) 2005-10-11 US disclosed
WO-2004072028-A2 PROCESS FOR PREPARING ORTHO SUBSTITUTED PHENYLAMINES CROMPTON CORPORATION (US) 2004-08-26 WO disclosed
US-20040162444-A1 Process for preparing ortho substituted phenylamines ADDIVANT USA, LLC 2004-08-19 US disclosed
US-5689007-A REACTING PHENYLHYDROXYAMINE WITH A NUCLEOPHILIC REAGENT INPRESENCE OF A HOMOGENEOUS ACID CATALYST UNIROYAL CHEMICAL COMPANY, INC. (US) 1997-11-18 US disclosed
US-5574187-A Process of preparing para substituted phenylamines UNIROYAL CHEMICAL COMPANY, INC. (US) 1996-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162444-A1 Process for preparing ortho substituted phenylamines PNMT, TYR, COMT L3MBTL1 2512/4885GABRA1 4348/4885GABRB2 4425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.